What to know about new diagnostic tools, targeted medications, and other recent advances in the treatment of metastatic NSCLC ...

Prepandemic severe spirometric obstruction, spirometric restriction, and increased emphysema on CT are linked to higher risk for severe COVID-19.

Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.